FDA Updates

New Rx, generics, and OTC products

Frustrated with the popular dehydration products available, pharmacists Sam and Jamie Lee began searching for alternatives after their 18-month-old son became sick and was in need of rehydration.

New Rx, indications, generics, and OTC products

It's time to tackle the unmentionables.

FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.

It's back-to-school season. Mom and Dad can be losing their hair for a few reasons - finding something crawling on the kids' heads is just the beginning. Here's a host of solutions for parents and their young.

New Rx, indications, generics, and OTC

FDA has approved pembrolizumab (Keytruda, Merck) for treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. Pembrolizumab, which received breakthrough therapy designation for advanced melanoma, is the sixth new melanoma treatment approved since 2011.

A University of Kentucky pharmacy professor has developed a quicker, easier way to deliver naloxone via a nasal spray, and his invention is being fast-tracked by the Food and Drug Administration, according to a report in the Lexington Herald-Leader.

NOH is a rare, chronic, and debilitating drop in blood pressure upon standing. It is associated with Parkinson's disease, multiple system atrophy, and pure autonomic failure.

New Rx, generics, and OTC

Summer's not over yet. For customers planning August vacations or anyone with active children, here are some new options for the first-aid kit.

FDA has approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease (COPD). The long-acting beta-adrenergic agonist (LABA) by Boehringer Ingelheim Pharmaceuticals can be used once daily as maintenance therapy.

New Rx, generics, OTC, and devices for pharmacists.

A besetting problem in a screen-obsessed age, dry eye can be distractingly painful. Several companies offers products that promise relief.

Approximately 7.8% of adults and 10% of children in the U.S. are afflicted with hay fever symptoms. Pharmacists are able to offer a number of over-the-counter solutions to improve patients' quality of life.

FDA approved eslicarbazepine acetate on November 8, 2013 as an adjunctive treatment of partial-onset seizures in adults.

New Rx, generics, and OTC for pharmacists

New Rx, new generics, and new OTC

Like oral medications, topical analgesics can offer patients well-controlled pain relief, but they do so without adverse systemic effects.

New Rx, formulations, indications, and generics

FDA has approved non-prescription esomeprazole 20mg (Nexium 24HR, Pfizer).

Bringing a new tool to the arsenal of medications to treat type 2 diabetes, FDA recently approved the only once-weekly injectable pen for adults with type 2 diabetes-exenatide extended-release for injectable suspension (AstraZeneca, Bydureon Pen).

In the pharmacy, an array of foot-care products awaits patients who can't stand it anymore.

New Rx, indications, generics, and OTC

Dr. Reddy’s Laboratories has launched moxifloxacin HCl tablets, 400 mg, a therapeutic equivalent generic version of Avelox on March 4, following FDA approval.

Teva Pharmaceutical Industries launched loxapine inhalation powder, 10 mg (Adasuve) March 3, for the acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults.

FDA approved droxidopa (Northera, Chelsea Therapeutics) capsules for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating condition that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.

FDA approved vortioxetine as oral tablets indicated for the treatment of major depressive disorder.

Brushes, toothpastes, rinses, whitestrips, and a gel pen -- lots of options for the dentally determined.